KMO and obesity due to melanocortin 4 receptor deficiency: Oxenkrug, van der Hart, Roeser, and Summergrad (2017) found that inhibition of peripheral KMO may be a new measure for the prevention of obesity and diabetes, and KMO expression in the adipose tissue was positively correlated with increased HbAlc level (Favennec et al., 2015).